{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T21:45:31Z","timestamp":1769723131037,"version":"3.49.0"},"reference-count":23,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2017.7483","type":"journal-article","created":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T07:04:08Z","timestamp":1511507048000},"source":"Crossref","is-referenced-by-count":4,"title":["BmK CT enhances the sensitivity of temozolomide-induced apoptosis of malignant glioma U251 cells in\u00ef\u00bf\u00bdvitro through blocking the AKT signaling pathway"],"prefix":"10.3892","author":[{"given":"Jun","family":"Du","sequence":"first","affiliation":[{"name":"Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Institute of Biotechnology, Shanxi University, Taiyuan, Shanxi 030006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruijie","family":"Wang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Institute of Biotechnology, Shanxi University, Taiyuan, Shanxi 030006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Litian","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Physiology, Key Laboratory of Cellular Physiology Co\u2011Constructed by Province and Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi 030006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuejun","family":"Fu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Institute of Biotechnology, Shanxi University, Taiyuan, Shanxi 030006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqing","family":"Cai","sequence":"additional","affiliation":[{"name":"Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Institute of Biotechnology, Shanxi University, Taiyuan, Shanxi 030006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Institute of Biotechnology, Shanxi University, Taiyuan, Shanxi 030006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aihua","family":"Liang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Institute of Biotechnology, Shanxi University, Taiyuan, Shanxi 030006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,11,24]]},"reference":[{"key":"key20200714001839_b1-ol-0-0-7483","doi-asserted-by":"publisher","first-page":"16384","DOI":"10.18632\/oncotarget.7650","article-title":"Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas","volume":"7","author":"Cai","year":"2016","journal-title":"Oncotarget"},{"key":"key20200714001839_b2-ol-0-0-7483","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cancergen.2012.10.009","article-title":"Genetics of adult glioma","volume":"205","author":"Goodenberger","year":"2012","journal-title":"Cancer Genet"},{"key":"key20200714001839_b3-ol-0-0-7483","doi-asserted-by":"publisher","first-page":"464","DOI":"10.4103\/0366-6999.176065","article-title":"Evolving molecular genetics of glioblastoma","volume":"129","author":"Li","year":"2016","journal-title":"Chin Med J (Engl)"},{"key":"key20200714001839_b4-ol-0-0-7483","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3322\/caac.20069","article-title":"Exciting new advances in neuro-oncology: The avenue to a cure for malignant glioma","volume":"60","author":"Van Meir","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"key20200714001839_b5-ol-0-0-7483","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.canlet.2016.01.024","article-title":"CGCG clinical practice guidelines for the management of adult diffuse gliomas","volume":"375","author":"Jiang","year":"2016","journal-title":"Cancer Lett"},{"key":"key20200714001839_b6-ol-0-0-7483","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1586\/ern.10.32","article-title":"Temozolomide: Therapeutic limitations in the treatment of adult high-grade gliomas","volume":"10","author":"Chamberlain","year":"2010","journal-title":"Expert Rev Neurother"},{"key":"key20200714001839_b7-ol-0-0-7483","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.canlet.2015.07.007","article-title":"NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells","volume":"367","author":"Yu","year":"2015","journal-title":"Cancer Lett"},{"key":"key20200714001839_b8-ol-0-0-7483","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S1368-7646(02)00120-6","article-title":"Activation of the PI3K\/Akt pathway and chemotherapeutic resistance","volume":"5","author":"West","year":"2002","journal-title":"Drug Resist Updat"},{"key":"key20200714001839_b9-ol-0-0-7483","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0065-230X(05)94002-5","article-title":"Activation of AKT kinases in cancer: Implications for therapeutic targeting","volume":"94","author":"Bellacosa","year":"2005","journal-title":"Adv Cancer Res"},{"key":"key20200714001839_b10-ol-0-0-7483","first-page":"2050","article-title":"Resveratrol reverses temozolomide resistance by downregulation of MGMT in T98G glioblastoma cells by the NF-\u03baB-dependent pathway","volume":"27","author":"Huang","year":"2012","journal-title":"Oncol Rep"},{"key":"key20200714001839_b11-ol-0-0-7483","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.neuroscience.2017.01.032","article-title":"The PI3K inhibitor GDC-0941 enhances radiosensitization and reduces chemoresistance to temozolomide in GBM cell lines","volume":"346","author":"Shi","year":"2017","journal-title":"Neuroscience"},{"key":"key20200714001839_b12-ol-0-0-7483","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-2407-14-17","article-title":"Enhanced cytotoxic effect of radiation and temozolomide in malignant glioma cells: Targeting PI3K-AKT-mTOR signaling, HSP90 and histone deacetylases","volume":"14","author":"Choi","year":"2014","journal-title":"BMC Cancer"},{"key":"key20200714001839_b13-ol-0-0-7483","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.canlet.2009.10.011","article-title":"BmKCT toxin inhibits glioma proliferation and tumor metastasis","volume":"291","author":"Fan","year":"2010","journal-title":"Cancer Lett"},{"key":"key20200714001839_b14-ol-0-0-7483","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s10529-011-0587-7","article-title":"A model of BmK CT in inhibiting glioma cell migration via matrix metalloproteinase-2 from experimental and molecular dynamics simulation study","volume":"33","author":"Fu","year":"2011","journal-title":"Biotechnol Lett"},{"key":"key20200714001839_b15-ol-0-0-7483","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neulet.2006.10.056","article-title":"Therapeutic potential of chlorotoxin-like neurotoxin from the Chinese scorpion for human gliomas","volume":"412","author":"Fu","year":"2007","journal-title":"Neurosci Lett"},{"key":"key20200714001839_b16-ol-0-0-7483","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1523\/JNEUROSCI.19-14-05942.1999","article-title":"Modulation of glioma cell migration and invasion using Cl(\u2212) and K(+) ion channel blockers","volume":"19","author":"Soroceanu","year":"1999","journal-title":"J Neurosci"},{"key":"key20200714001839_b17-ol-0-0-7483","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.3892\/or.2016.5089","article-title":"Combination of lentivirus-mediated silencing of PPM1D and temozolomide chemotherapy eradicates malignant glioma through cell apoptosis and cell cycle arrest","volume":"36","author":"Wang","year":"2016","journal-title":"Oncol Rep"},{"key":"key20200714001839_b18-ol-0-0-7483","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1158\/1541-7786.MCR-08-0428","article-title":"p53 mutant human glioma cells are sensitive to UV-C-induced apoptosis due to impaired cyclobutane pyrimidine dimer removal","volume":"7","author":"Batista","year":"2009","journal-title":"Mol Cancer Res"},{"key":"key20200714001839_b19-ol-0-0-7483","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200714001839_b20-ol-0-0-7483","first-page":"241","article-title":"Comparison of methods for evaluating drug-drug interaction","volume":"2","author":"Zhao","year":"2010","journal-title":"Front Biosci (Elite Ed)"},{"key":"key20200714001839_b21-ol-0-0-7483","doi-asserted-by":"crossref","unstructured":"CantleyLCNeelBGNew insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase\/AKT pathwayProc Natl Acad Sci USA9642404245199910.1073\/pnas.96.8.424010200246","DOI":"10.1073\/pnas.96.8.4240"},{"key":"key20200714001839_b22-ol-0-0-7483","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1158\/1078-0432.CCR-07-1719","article-title":"Mechanisms of chemoresistance to alkylating agents in malignant glioma","volume":"14","author":"Sarkaria","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20200714001839_b23-ol-0-0-7483","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1158\/1535-7163.MCT-08-0680","article-title":"Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells","volume":"8","author":"Gallia","year":"2009","journal-title":"Mol Cancer Ther"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:51:08Z","timestamp":1594687868000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2017.7483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,24]]},"references-count":23,"URL":"https:\/\/doi.org\/10.3892\/ol.2017.7483","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,24]]}}}